Rocío Rubio

699 total citations
10 papers, 84 citations indexed

About

Rocío Rubio is a scholar working on Infectious Diseases, Modeling and Simulation and Immunology. According to data from OpenAlex, Rocío Rubio has authored 10 papers receiving a total of 84 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Infectious Diseases, 3 papers in Modeling and Simulation and 2 papers in Immunology. Recurrent topics in Rocío Rubio's work include SARS-CoV-2 and COVID-19 Research (9 papers), COVID-19 Clinical Research Studies (6 papers) and COVID-19 epidemiological studies (3 papers). Rocío Rubio is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (9 papers), COVID-19 Clinical Research Studies (6 papers) and COVID-19 epidemiological studies (3 papers). Rocío Rubio collaborates with scholars based in Spain, Canada and Mozambique. Rocío Rubio's co-authors include Carlota Dobaño, Ruth Aguilar, Marta Vidal, Gemma Moncunill, Natalia Rodrigo Melero, Carlo Carolis, Luís Izquierdo, Anna Ramírez‐Morros, Selena Alonso and Pau Serra and has published in prestigious journals such as Nature Communications, Frontiers in Immunology and Vaccine.

In The Last Decade

Rocío Rubio

8 papers receiving 83 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Rocío Rubio Spain	6	53	26	17	16	13	10	84
Jessica N. Ricaldi United States	4	24 0.5×	36 1.4×	7 0.4×	29 1.8×	12 0.9×	8	73
Afsaneh Ghasemzadeh Iran	5	45 0.8×	7 0.3×	7 0.4×	4 0.3×	6 0.5×	19	83
Shelcie Fabre United States	3	62 1.2×	10 0.4×	4 0.2×	5 0.3×	25 1.9×	7	81
Léon Bergfeld Germany	3	53 1.0×	8 0.3×	5 0.3×	11 0.7×	6 0.5×	4	61
Robin Šín Czechia	5	36 0.7×	7 0.3×	5 0.3×	6 0.4×	3 0.2×	14	57
Nicolás Kreplak Argentina	5	97 1.8×	16 0.6×	6 0.4×	3 0.2×	14 1.1×	12	110
Caroline Eisele United States	4	23 0.4×	5 0.2×	10 0.6×	22 1.4×	7 0.5×	18	84
Brian Pui-Chun Chan Hong Kong	5	105 2.0×	7 0.3×	6 0.4×	3 0.2×	7 0.5×	11	130
Bonnie Dighero-Kemp United States	5	44 0.8×	3 0.1×	14 0.8×	7 0.4×	5 0.4×	6	63
Selena Alonso Spain	5	45 0.8×	3 0.1×	10 0.6×	6 0.4×	12 0.9×	8	58

Countries citing papers authored by Rocío Rubio

Since Specialization

Citations

This map shows the geographic impact of Rocío Rubio's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rocío Rubio with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rocío Rubio more than expected).

Fields of papers citing papers by Rocío Rubio

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rocío Rubio. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rocío Rubio. The network helps show where Rocío Rubio may publish in the future.

Co-authorship network of co-authors of Rocío Rubio

This figure shows the co-authorship network connecting the top 25 collaborators of Rocío Rubio. A scholar is included among the top collaborators of Rocío Rubio based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rocío Rubio. Rocío Rubio is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

Ramírez‐Morros, Anna, Alfons Jiménez, Marta Vidal, et al.. (2025). Determinants of antibody levels and protection against omicron BQ.1/XBB breakthrough infection. Communications Medicine. 5(1). 243–243.

Ranzani, Otávio T., Rocío Rubio, Anna Ramírez‐Morros, et al.. (2025). Primary SARS-CoV-2 exposure by vaccination or infection shapes immune responses to omicron variants among a Spanish cohort. Nature Communications. 17(1). 863–863. 1 indexed citations

Rubio, Rocío, Dídac Macià, Diana Barrios, et al.. (2024). High-resolution kinetics and cellular determinants of SARS-CoV-2 antibody response over two years after COVID-19 vaccination. Microbes and Infection. 27(2). 105423–105423. 5 indexed citations

Rubio, Rocío, Alexei Yavlinsky, Marina Escalera Zamudio, et al.. (2024). Initial antigen encounter determines robust T-cell immunity against SARS-CoV-2 BA.2.86 variant three years later. Journal of Infection. 90(2). 106402–106402. 2 indexed citations

Karachaliou, Marianna, Ana Espinosa, Xavier Farré, et al.. (2024). Mental illness and antibody responses after COVID-19 vaccination in a prospective population-based study in Catalonia. Vaccine. 45. 126591–126591.

Dobaño, Carlota, Anna Ramírez‐Morros, Selena Alonso, et al.. (2022). Sustained seropositivity up to 20.5 months after COVID-19. BMC Medicine. 20(1). 379–379. 11 indexed citations

Rubio, Rocío, Ruth Aguilar, Mariona Bustamante, et al.. (2022). Maternal and neonatal immune response to SARS-CoV-2, IgG transplacental transfer and cytokine profile. Frontiers in Immunology. 13. 999136–999136. 26 indexed citations

Dobaño, Carlota, Anna Ramírez‐Morros, Selena Alonso, et al.. (2022). Eleven‐month longitudinal study of antibodies in SARS‐CoV‐2 exposed and naïve primary health care workers upon COVID‐19 vaccination. Immunology. 167(4). 528–543. 7 indexed citations

Dobaño, Carlota, Alfons Jiménez, Rocío Rubio, et al.. (2021). Spike-based COVID-19 immunization increases antibodies to nucleocapsid antigen. Translational research. 240. 26–32. 8 indexed citations

10.

Dobaño, Carlota, Anna Ramírez‐Morros, Selena Alonso, et al.. (2021). Persistence and baseline determinants of seropositivity and reinfection rates in health care workers up to 12.5 months after COVID-19. BMC Medicine. 19(1). 155–155. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact